<DOC>
	<DOCNO>NCT00430612</DOCNO>
	<brief_summary>The purpose PACE-MI ( OBTAIN ) registry : - Analyze beta-blocker dose response effect outcome two year - Explore gender minority difference beta-blocker utilization outcome . In patient Myocardial Infarction ( MI ) discharge hospital , beta-blocker dose predictive survival . Exploratory analysis : Gender racial effectsâ€”gender race , similarly , hypothesize predictive post-MI survival . The existence interaction gender beta-blocker effect well race beta-blocker effect also evaluate .</brief_summary>
	<brief_title>The PACE-MI Registry Study - Outcomes Beta-blocker Therapy After Myocardial Infarction ( OBTAIN )</brief_title>
	<detailed_description>Methods All patient admit coronary care area acute myocardial infarction enter registry . At time discharge coronary care unit , clinical data enter . The registry include approximately 6800 patient . As intervention registry , data collect standard quality assurance purpose practicably carry without waiver consent HIPAA authorization , consent specifically registry patient baseline . Systems implemented ensure registry data remain confidential . Sites received IRB approval waiver consent HIPAA baseline registry data . Data collect include demographic ( include ethnic race classification accord NIH guideline ) data information regard index myocardial infarction . Use beta-blockers discharge coronary care unit document . In addition , beta-blocker use hospital discharge note . Data registry obtain ER note , admission note , cardiac catheterization lab report , medication list , lab report , discharge summary . Follow-Up Follow-up registry patient conduct year 1 year 2 post-myocardial infarction . Data may obtain via medical chart review , phone contact , Social Security Death Index ( SSDI ) . For follow-up information obtain via chart review SSDI , detailed justification waiver HIPAA consent requirement attach protocol ( see appendix 7 ) . If phone contact require patient , suggest follow process : - A letter send patient approximately one week prior contact rationale study provide , well delineation patient 's right participate participate ( either provide provide request information ) . - At telephone contact patient , coordinator document whether patient consent provide information . If patient consent , coordinator proceed obtain requested information . - In event participate institution 's IRB require write , sign consent verbal contact , write consent form template ( see appendix 3 ) provide . Data collect follow-up interview include vital status , beta-blocker use , cardiac medication cardiovascular hospitalization .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>Inclusion Criteria 1 . Consecutive patient admit myocardial infarction document follow : 1. cardiac enzyme ( CPK elevation &gt; two time troponin elevation &gt; three time upper limit normal lab ) 2 . Electrocardiographic change and/or symptom consistent myocardial infarction ( i.e . chest pain , shortness breath ) No Exclusion Criteria</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Heart Attack</keyword>
	<keyword>Beta Blockers</keyword>
	<keyword>Survival</keyword>
</DOC>